Recent Quarter Total Invested
$4.42 B
Recent Quarter Institutional Ownership Percentage
93.11%
Total Invested of Last Quarter
$6.58 B
Ownership Percentage of Last Quarter
91.11%
Apellis Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 16.39 M | $628.67 M | 8.84% | 13.23% |
| ECOR1 CAPITAL, LLC | 08/14/2024 | 11.61 M | $445.26 M | 2.20% | 9.37% |
| AVORO CAPITAL ADVISORS LLC | 08/14/2024 | 11.11 M | $426.22 M | 0.00% | 8.97% |
| VANGUARD GROUP INC | 08/13/2024 | 9.81 M | $376.29 M | 3.19% | 7.92% |
| BLACKROCK INC. | 08/13/2024 | 5.80 M | $222.31 M | 5.47% | 4.71% |
| STATE STREET CORP | 08/14/2024 | 4.15 M | $159.07 M | 42.52% | 3.35% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2024 | 4.05 M | $155.30 M | -12.10% | 3.27% |
| JENNISON ASSOCIATES LLC | 08/05/2024 | 3.59 M | $137.77 M | 10.83% | 2.90% |
| FMR LLC | 08/13/2024 | 3.30 M | $126.58 M | 51.45% | 2.66% |
| JPMORGAN CHASE & CO | 08/12/2024 | 3.18 M | $121.89 M | 43.50% | 2.56% |
| OCTAGON CAPITAL ADVISORS LP | 08/14/2024 | 2.88 M | $110.51 M | 2.63% | 2.33% |
| DEEP TRACK CAPITAL, LP | 08/14/2024 | 2.50 M | $95.90 M | 150.00% | 2.02% |
| MORGAN STANLEY | 10/17/2024 | 2.12 M | $81.28 M | 29.39% | 1.71% |
| LOGOS GLOBAL MANAGEMENT LP | 08/27/2024 | 2.00 M | $76.72 M | 100.00% | 1.61% |
| DEUTSCHE BANK AG\ | 08/14/2024 | 1.84 M | $70.66 M | 14.29% | 1.49% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.79 M | $68.60 M | 5.80% | 1.44% |
| BOXER CAPITAL, LLC | 08/14/2024 | 1.73 M | $66.21 M | 0.00% | 1.39% |
| ARTAL GROUP S.A. | 08/14/2024 | 1.47 M | $56.28 M | 11.54% | 1.18% |
| FIERA CAPITAL CORP | 10/31/2024 | 1.40 M | $53.75 M | 47.74% | 1.13% |
| ORBIMED ADVISORS LLC | 08/14/2024 | 1.30 M | $49.98 M | 0.39% | 1.05% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 1.28 M | $48.96 M | -48.10% | 1.03% |
| INVESCO LTD. | 08/13/2024 | 1.10 M | $42.30 M | 44.71% | 0.89% |
| NORGES BANK | 08/14/2024 | 1.08 M | $41.41 M | 100.00% | 0.87% |
| POLAR CAPITAL HOLDINGS PLC | 08/14/2024 | 1.08 M | $41.41 M | 2.37% | 0.87% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 1.03 M | $39.46 M | 219.70% | 0.83% |
| CAPTION MANAGEMENT, LLC | 08/14/2024 | 1.00 M | $38.54 M | 1,574.50% | 0.81% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 995,069 | $38.17 M | 37.55% | 0.80% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 947,034 | $36.33 M | 2.43% | 0.76% |
| EAGLE ASSET MANAGEMENT INC | 08/12/2024 | 802,253 | $29.11 M | -5.12% | 0.65% |
| AMERIPRISE FINANCIAL INC | 08/14/2024 | 783,914 | $30.07 M | 47.53% | 0.63% |
| ASSENAGON ASSET MANAGEMENT S.A. | 07/18/2024 | 734,708 | $28.18 M | -63.69% | 0.59% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 08/14/2024 | 689,108 | $26.43 M | 100.00% | 0.56% |
| BRAIDWELL LP | 08/14/2024 | 611,800 | $23.47 M | 100.00% | 0.49% |
| CANDRIAM S.C.A. | 08/05/2024 | 543,035 | $20.83 M | -7.16% | 0.44% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 478,963 | $18.37 M | 96.09% | 0.39% |
| NORTHERN TRUST CORP | 08/14/2024 | 462,218 | $17.73 M | 4.94% | 0.37% |
| VICTORY CAPITAL MANAGEMENT INC | 08/05/2024 | 461,866 | $17.72 M | -6.11% | 0.37% |
| BELLEVUE GROUP AG | 08/14/2024 | 444,404 | $17.05 M | -6.23% | 0.36% |
| NEW YORK STATE COMMON RETIREMENT FUND | 07/31/2024 | 431,113 | $16.54 M | 32.27% | 0.35% |
| CAPTION MANAGEMENT, LLC | 08/14/2024 | 430,000 | $16.49 M | 1,287.10% | 0.35% |
| LOGOS GLOBAL MANAGEMENT LP | 08/27/2024 | 400,000 | $15.34 M | -50.00% | 0.32% |
| OCTAGON CAPITAL ADVISORS LP | 08/14/2024 | 350,000 | $13.43 M | 75.00% | 0.28% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 345,195 | $13.24 M | 6.90% | 0.28% |
| VESTAL POINT CAPITAL, LP | 08/14/2024 | 335,000 | $12.85 M | 48.89% | 0.27% |
| TD ASSET MANAGEMENT INC | 08/02/2024 | 311,832 | $11.96 M | -32.12% | 0.25% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 280,001 | $10.74 M | 3.48% | 0.23% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 274,900 | $10.55 M | -16.97% | 0.22% |
| UBS GROUP AG | 08/14/2024 | 272,397 | $10.45 M | 144.76% | 0.22% |
| PICTET ASSET MANAGEMENT HOLDING SA | 08/13/2024 | 253,048 | $9.71 M | -76.42% | 0.20% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2024 | 246,880 | $9.18 M | 337.27% | 0.20% |
Apellis Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of APLS shares?
During the previous two years, 322 institutional investors and hedge funds held shares of Apellis Pharmaceuticals, Inc.. The most heavily invested institutionals were:
WELLINGTON MANAGEMENT GROUP LLP: 15.57 M
EcoR1 Capital, LLC: 11.89 M
BlackRock Funding, Inc. /DE: 6.19 M
Deep Track Capital, LP: 4.4 M
STATE STREET CORP: 4.04 M
JPMORGAN CHASE & CO: 3.88 M
-
What percentage of Apellis Pharmaceuticals, Inc. stock is owned by institutional investors?
93.11% of Apellis Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at APLS ?
Institutional investors have bought a total of 97.98 M shares in the last 24 months. This purchase volume represents approximately $2.72 B in transactions.